Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Phase 1 Unknown 15 enrolled Beth Israel Deaconess Medical Center

Treatment

Summary

RATIONALE: Boron neutron capture therapy may selectively kill tumor cells without harming normal tissue. PURPOSE: Phase I trial to study the effectiveness of boron neuron capture therapy in treating patients with stage III melanoma.

Timeline

Start: 1996-04
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	boronophenylalanine-fructose complex	Unknown	—	—

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Summary

Timeline

Drugs

Indications